Vaxart, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
Vaxart, Inc. (VXRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate of 0.67% for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate · last filed 2017-09-01
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2017-03-31 was 0.65%, a 14.47% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2016-09-30 was 0.76%, a 1.33% increase year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2016-03-31 was 0.76%, a 2.56% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2015-09-30 was 0.75%, a 8.54% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2017 was 0.67%, a 10.67% decline from fiscal 2016.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2016 was 0.75%, a 8.54% decline from fiscal 2015.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2015 was 0.82%, a 3.80% increase from fiscal 2014.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2014 was 0.79%, a 0.00% change from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 12 month |
|---|---|---|---|---|
| 2017-06-30 | 0.67% 10-K · filed 2017-09-01 | |||
| 2017-03-31 | 0.65% 10-Q · filed 2017-05-08 | 0.71% 10-Q · filed 2017-05-08 | ||
| 2016-09-30 | 0.76% 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | 0.75% 10-K · filed 2017-09-01 | |||
| 2016-03-31 | 0.76% 10-Q · filed 2017-05-08 | 0.75% 10-Q · filed 2017-05-08 | ||
| 2015-09-30 | 0.75% 10-Q · filed 2016-11-08 | |||
| 2015-06-30 | 0.82% 10-K · filed 2016-09-13 | |||
| 2015-03-31 | 0.78% 10-Q · filed 2015-05-08 | 0.82% 10-Q · filed 2015-05-08 | ||
| 2014-12-31 | 0.82% 10-Q · filed 2015-02-06 | 0.82% 10-Q · filed 2015-02-06 | ||
| 2014-09-30 | 0.82% 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | 0.79% 10-K · filed 2016-09-13 | |||
| 2014-03-31 | 0.78% 10-Q · filed 2015-05-08 | 0.78% 10-Q · filed 2015-05-08 | ||
| 2013-12-31 | 0.78% 10-Q · filed 2015-02-06 | 0.78% 10-Q · filed 2015-02-06 | ||
| 2013-06-30 | 0.79% 10-K · filed 2015-09-11 | |||
| 2013-03-31 | 0.84% 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | 0.84% 10-Q · filed 2014-02-10 | 0.84% 10-Q · filed 2014-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |